Virtue Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Sell
671
-68
-9% -$23.3K 0.03% 311
2026
Q1
$258K Buy
739
+49
+7% +$17.5K 0.04% 280
2025
Q4
$226K Buy
+690
New +$219K 0.03% 280
2025
Q2
Sell
-2,656
Closed -$828K 265
2025
Q1
$828K Buy
2,656
+1,881
+243% +$555K 0.1% 172
2024
Q4
$202K Buy
775
+95
+14% +$28.2K 0.04% 244
2024
Q3
$219K Sell
680
-188
-22% -$61.5K 0.04% 244
2024
Q2
$289K Sell
868
-55
-6% -$16.2K 0.05% 291
2024
Q1
$246K Buy
923
+127
+16% +$37.2K 0.04% 326
2023
Q4
$241K Sell
796
-682
-46% -$186K 0.05% 322
2023
Q3
$334K Hold
1,478
0.06% 283
2023
Q2
$334K Buy
1,478
+499
+51% +$116K 0.06% 283
2023
Q1
$234K Sell
979
-3
-0.3% -$736 0.04% 347
2022
Q4
$258K Sell
982
-32
-3% -$8.58K 0.04% 316
2022
Q3
$228K Buy
+1,014
New +$246K 0.04% 223
2021
Q3
Sell
-4,903
Closed -$1.2M 379
2021
Q2
$1.2M Sell
4,903
-177
-3% -$43.5K 0.24% 123
2021
Q1
$1.26M Sell
5,080
-1,628
-24% -$388K 0.3% 97
2020
Q4
$1.54M Sell
6,708
-610
-8% -$141K 0.38% 69
2020
Q3
$1.86M Buy
7,318
+265
+4% +$65.7K 0.46% 58
2020
Q2
$1.66M Buy
+7,053
New +$1.61M 0.38% 76
2019
Q4
Sell
-4,040
Closed -$782K 240
2019
Q3
$782K Sell
4,040
-859
-18% -$165K 0.26% 117
2019
Q2
$903K Buy
+4,899
New +$877K 0.33% 97
2019
Q1
Sell
-1,339
Closed -$261K 116
2018
Q4
$261K Sell
1,339
-6,935
-84% -$1.35M 0.12% 65
2018
Q3
$1.72M Buy
8,274
+3,888
+89% +$766K 0.36% 75
2018
Q2
$810K Buy
4,386
+347
+9% +$61.4K 0.39% 71
2018
Q1
$705K Sell
4,039
-78
-2% -$14.3K 0.37% 83
2017
Q4
$716K Buy
+4,117
New +$729K 0.41% 52

Other funds holding AMGN

Virtue Capital Management's AMGN Position: Q2 2026 in Review

Virtue Capital Management reduced its Amgen (AMGN) stake by 9.2% in Q2 2026, selling an estimated $23.3K and leaving 671 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #311.

Virtue Capital Management first reported a position in AMGN in Q4 2017 and has held it in 26 quarters since. The position peaked at $1.86M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Virtue Capital Management held 671 shares of Amgen worth $243K as of Q2 2026.
  • Virtue Capital Management sold 68 Amgen shares in Q2 2026, an estimated $23.3K.
  • Amgen made up 0.03% of Virtue Capital Management's portfolio in Q2 2026, its #311 holding.
  • Virtue Capital Management first reported a position in Amgen in Q4 2017 and has held it in 26 quarters since.
  • Virtue Capital Management's Amgen position peaked at $1.86M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.